Mucopolysaccharidosis Type II - 3 Studies Found
| Recruiting |
: Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome : : 2025-08-02 |
| Active, not recruiting |
: Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment : : 2025-08-02 |
| Completed |
: Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A) : Mucopolysaccharidosis Type IIIA : 2025-08-02 : intravenous repeating dose |